• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

‘Why our NHS trust turned to pharmacies to screen patients for AF’

    Home Case Studies ‘Why our NHS trust turned to pharmacies to screen patients for AF’
    NextPrevious

    ‘Why our NHS trust turned to pharmacies to screen patients for AF’

    By admin | Case Studies | Comments are Closed | 8 January, 2018 | 0

    The story of how a partnership between community pharmacists and a hospital trust in London is helping to detect undiagnosed atrial fibrillation (AF) as part of a ‘Capture AF’ project, using NIA innovation, AliveCor’s Kardia.

    This article was first published on the C+D website – www.chemistanddruggist.co.uk/feature/nhs-trust-used-pharmacists-AF-screening – on 19 December 2017, reported by Annabelle Collins, Deputy News Editor.

    It isn’t often that a community pharmacist and a consultant cardiologist are sat side by side as colleagues. But this is just one of the achievements of Capture AF – along with winning the 2017 C+D Award for Health Initiative of the Year.

    The charity AF Association estimates that atrial fibrillation (AF) affects over one million people in the UK, and is most common in the over 65 age group – so the Capture AF scheme targeted these patients.

    The project’s aim was threefold: increase the detection of undiagnosed AF, improve anticoagulation prescribing in undiagnosed patients, and facilitate early referrals to the specialist centre at the Harefield Hospital in Hillingdon, London.

    The Capture AF team: (left to right) community pharmacist Rikin Patel; hospital pharmacist Zainab Khanbhai; lead arrhythmia pharmacist Sally Manning; and cardiologist Dr Wajid Hussain. (Photo credit: Annabelle Collins, C+D)

    The collaborative outreach scheme involved ten community pharmacies in Hillingdon, London and the Royal Brompton and Harefield NHS Foundation Trust’s specialist arrhythmia care team, working together to refer and treat patients. In the six month-long data collection phase of the project, the team tested 600 patients for AF, and there are plans to roll it out to reach 3,000 patients across 30 pharmacies.

    Getting the project off the ground

    Sally Manning, lead arrhythmia pharmacist at the trust, explains that she wanted to create a project involving community pharmacists.

    “It was on a piece of scrap paper initially,” she says. “There were other projects where GPs were looking at detecting AF, and it made me think it was something that community pharmacists could be involved in.”

    She then took the idea to Dr Wajid Hussain, consultant cardiologist and clinical governance lead for the arrhythmia care group at the Royal Brompton and Harefield hospitals.

    “I thought it was a great idea,” Dr Hussain tells C+D. “It ticked a lot of boxes, helped extend [Ms Manning’s] role into research, extended our links to the community, and most importantly, helped patients.

    “One of the big problems [with AF] is under detection,” he says. “Why wouldn’t we do it?”

    AliveCor Kardia
    AliveCor's Kardia, the mobile ECG device used as part of the Capture AF project.

    Funding the project

    Ms Manning applied for a grant from charity The Health Foundation – which Dr Hussain describes as: “not an inconsiderable feat”. The scheme was awarded £70,000, which Ms Manning says recognised the strength of the project.

    Shortly after this, Zainab Khanbhai – a senior pharmacist at the trust – came on board as Capture AF project lead, and Rikin Patel, a community pharmacist and vice-chair of Hillingdon local pharmaceutical committee, was approached.

    “Originally we were [going to] work with pharmacists in North Hillingdon, but we realised we needed to broaden the scope,” Ms Khanbhai explains.

    Mr Patel says: “Sally made contact with me fairly early on to see if this would work in community pharmacy and I thought, yes, we can make this work. [She] did all the hard work in terms of getting the funding, and we thrashed out the logistics of it in the community pharmacies.”

    Capturing pharmacists’ enthusiasm

    Ms Manning describes how the team was “inundated with people coming forward”, who thought it was a great idea and wanted to get involved.

    “One of the things that has been a real eye-opener for me was the enthusiasm of the community pharmacists,” Dr Hussain says. “My thought process, which was incorrect, was that they are [only] business owners.”

    “The first meeting we had was remarkable,” he says. “Up until then, I had been a bit sceptical. I went to that meeting and saw how keen the pharmacists were – it has been amazing actually.”

    In order to attract patients, the team produced an eye-catching poster to display in pharmacies (see below), and trained 10 community pharmacists to undertake the screening.

    “[The pharmacists] had training from Sally and myself regarding AF symptoms [and] how to detect it, and how to use the cardio monitor,” says Ms Khanbhai. “We had a community pharmacy working group, and we were quite involved in the training from the beginning.”

    Ms Manning adds that it was important community pharmacists could reassure, as well as screen, patients. “We needed to train the community pharmacists about how they would manage [a patient with AF], how they would alleviate any fears, and how patients would get directly referred to the Harefield Hospital and seen by a specialist team.”

    The screening test itself involves using an app and a mobile electrocardiogram (ECG) recorder, which Dr Hussain says is “very acceptable for patients”, as they simply place their thumbs on the recorder.

    “There are no blood tests,” he points out, and it also differs from ECG screens, where people sometimes “have to take their clothes off, which is off-putting”.

    What were the challenges?

    Despite the simplicity of the test, the project was not without challenges, specifically around confidentiality and data protection. “There were a lot of challenges around sending data from primary care across to secondary care,” says Ms Manning.

    Ms Khanbhai expands: “We needed [patient data] sent across to us in a certain way.” The solution came when the team discovered that “PharmOutcomes could pseudonymise the data”.

    For example, a patient’s date of birth was changed to their age and their name into their initials. This meant “we could figure out who they were [just] by having those details”.

    The ECG reading was sent via NHS email, but this presented another problem, as not all community pharmacies have an NHS email account.

    “The IT was a real challenge,” says Dr Hussain. “It’s crazy [pharmacists] don’t have a secure way of electronic transfer. The data was simple and straightforward.”

    However, despite having to navigate tricky IT issues, the team tested 600 patients, and detected possible signs of AF in 54 people. From this cohort, 15 patients were eventually diagnosed with AF – most of whom did not display any symptoms that would have enabled the condition to be spotted otherwise.

    Plans to expand

    The scheme was so successful that plans to upscale the project are already well underway – with the aim of launching by early 2018.

    Ms Manning says “we have been awarded a grant of £100,000 to continue”, along with NHS funding for the cardio monitors.

    Dr Hussain explains that the principles will be the same as the original Capture AF project: a “tight interface” between community pharmacists and the arrhythmia team in order to make a streamlined path for the patient.

    However, there will be some differences, which will draw even more on the clinical expertise within community pharmacy. “We will be focused on adherence this time around,” Ms Khanbhai explains. In the extended project, patients will be referred back to their community pharmacist for a medicines use review.

    Dr Hussain says: “We know that people who stop taking their medicines have a much higher risk of stroke.”

    “That is where community pharmacists are well-placed,” says Mr Patel. “Patients are given the opportunity to discuss their medication.”

    “We are hoping it will spread,” Dr Hussain adds. “It’s such an obviously good thing – why didn’t someone do this before?”

    The C+D Award judges said the Capture AF project “captures the essence of community pharmacy, by providing a service which identifies patients at risk, improves outcomes, reduces NHS costs and saves lives”.

    No tags.

    Related Posts

    • The new palliative care gold standard

      By admin | Comments are Closed

      By: Julia Riley The EIU’s recent Quality of Death report praised palliative care in the UK as the best in the world, citing the quality and availability of services provided by the NHS and hospice movement as “second toRead more

    • Nervecentre Software win prestigious Building Better Healthcare Award

      By admin | Comments are Closed

      Nervecentre Software in partnership with Nottingham University Hospitals NHS Trust have won the prestigious award for ‘Best Communications and IT product’ at the Building Better Healthcare Awards, held on 4th November 2015, The award isRead more

    • Southend University Hospital NHS Foundation Trust live with Nervecentre electronic observations

      By admin | Comments are Closed

      Southend University Hospital NHS Foundation Trust has now deployed Nervecentre Electronic Observations software using mobiles devices across the hospitals to improve patient safety and communications. Funded through the Nursing Technology Fund, Electronic Observations are now liveRead more

    • Nervecentre in Australia… Success at the ISRRS Symposium in Melbourne


      By admin | Comments are Closed

      Written by Jim Trueman Attendees of the symposium held by the International Society for Rapid Response Systems and Medical Emergency Teams are all clinicians that intuitively recognise the problems that Nervecentre was designed to solve. Read more

    • i-THRIVE: Manchester and Salford’s Integrated Access and Care Pathways 


      By admin | Comments are Closed

      What was the problem you were trying to solve? Central Manchester University Hospitals NHS Foundation Trust (CMFT) provide child and adolescent mental health services (CAMHS) for Manchester and Salford. The move towards Integrated Access andRead more

    • Coordinate My Care Integrates Care Plans into Emis Web

      By admin | Comments are Closed

      Urgent care plans for thousands of London’s most vulnerable patients care are now just a click away for almost 1,000 of their GPs. Plan sharing scheme Coordinate my Care will now be available to 962Read more

    • OWise breast cancer app proven to be effective tool in cancer treatment process

      By admin | Comments are Closed

      Innovative patient support app shown in peer-reviewed medical journal to improve patient-doctor interactions and is recommended by 90% of patients and clinicians OWise breast cancer, the first mobile app to offer patients personalised medical supportRead more

    • OBH featured in TeleMedicine Magazine

      By admin | Comments are Closed

      Telemedicine Magazine included an article on Outcome Based Healthcare (OBH) in their series focusing on the growing trend of doctors getting involved with healthcare start-ups. Rupert, OBH CEO, explained that during his time as aRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA